Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor, Y-linked 2 (HSFY2) encodes a member of the heat shock factor (HSF) family, acting as a transcriptional activator of heat shock proteins. It is found exclusively on the Y chromosome in humans and is present as two identical copies in a palindromic region. Alternative splicing yields multiple isoforms. HSFY2 is frequently deleted in some infertile males, indicating a critical role in spermatogenesis. It functions by binding DNA at specific sites to regulate the expression of genes involved in responding to cellular stress, particularly heat shock proteins. While it is not a drug target in itself, its presence or absence may serve as a biomarker relevant to the genetic diagnosis of male infertility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock transcription factor, Y-linked 2 (HSFY2).